摘要
目的:比较SMILE与FS-LASIK术后屈光回退发生情况,分析屈光回退相关因素。方法:回顾性选取2020.1-2021.12于贵州医科大学附属医院行SMILE、FS-LASIK手术患者112例(224眼),按手术术式不同分为全飞组(104眼)和半飞组(120眼)。于术后2年统计屈光回退情况,分为屈光回退组和无屈光回退组,分析相关因素。结果:术后随访2年内,两组屈光回退率相比有差异(P<0.045)。屈光回退组术前术后曲率差值、术前近视屈光度、术后角膜曲率变化幅度均高于无屈光回退组(P<0.05)。多因素回归分析显示,术前术后曲率差值、术前近视屈光度、术后角膜曲率变化幅度均是屈光回退的相关因素(P<0.05)。三指标联合预测屈光回退的AUC值高于单项预测(P<0.05)。结论:两种术式预后屈光回退率相当,术前术后曲率差值、术前近视屈光度、术后角膜曲率变化幅度均是屈光回退的相关因素,且各指标联合预测预后屈光回退价值好。
Objective:To compare the occurrence of postoperative refractive regression between SMILE and FS-LASIK and to analyze the factors associated with refractive regression.Methods:Retrospectively selected 112(224 eyes)patients who underwent SMILE and FS-LASIK in The Affiliated Hospital of Guizhou Medical University,and were divided into total flying group(104 eyes)and half flying group(120 eyes)according to different surgical types.At 2 years after surgery,the refractive regression situation was divided into refractive regression group and no-refractive rebound group,and the related factors were analyzed.Results:There was was difference between the two groups(P<0.045).The difference of preoperative curvature,preoperative myopia refraction,and postoperative corneal curvature in the refractive group were higher than those in the nonrefractive group(P<0.05).Multivariate regression analysis showed that the difference of preoperative and postoperative curvature,preoperative myopic refraction,and the amplitude of postoperative corneal curvature were all factors associated with refractive regression(P<0.05).The AUC value of the three indicators was higher than the individual prediction(P<0.05).Conclusion:The prognosis of the two types is comparable.The difference of preoperative and postoperative curvature,preoperative myopia refraction and postoperative corneal curvature are all related factors of refractive regression,and the combination of all indicators to predict the prognosis value of refractive regression is good.
作者
柳昊熹
张丽颖
沈柏宇
祝思琪
吴珂
LIU Hao-xi;ZHANG Li-ying;SHEN Bo-yu;ZHU Si-qi;WU Ke(Department of Ophthalmology,The Affiliated Hospital of Guizhou Medical University,Guiyang,Guizhou,550004,China)
出处
《现代生物医学进展》
CAS
2024年第19期3775-3777,共3页
Progress in Modern Biomedicine
基金
国家自然科学基金地区项目(82060173)。